Retro Biosciences

Retro Biosciences develops therapies intended to meaningfully reverse age-related diseases. The company targets aging mechanisms to increase healthy lifespan, focusing on the cellular drivers of aging to design therapeutics that will eventually prevent and reverse age-related diseases. It identifies aging mechanisms for which interventions have shown robust proofs of concept in mammals and have a feasible path to translation to humans, and it aspires to be a generational pharma company built as a portfolio of bets.

Retro Biosciences develops therapies that meaningfully reverse age-related diseases. Its strategy targets aging mechanisms to increase healthy lifespan and targets age-related diseases at their source. The company focuses on cellular drivers of aging to design therapeutics that will eventually prevent and reverse age-related diseases, and it identifies aging mechanisms for which interventions have shown robust proofs of concept in mammals and have a feasible path to translation to humans. Retro aspires to be a generational pharma company proportional to the scale of its mission, built as a portfolio of bets and driven by a culture of kindness, rigor, and versatility, prizing speed through rapid iteration and investment in vertical integration.

A different kind of biotech aspiring to be a generational pharma company proportional to the scale of its mission, built as a portfolio of bets and driven by a culture of kindness, rigor, and versatility.

1. 1Retro Biosciences | Healthy Human Lifespanretro.bio